The genetics of NAFLD (original) (raw)

• Anstee, Q. M., McPherson, S. & Day, C. P. How big a problem is non-alcoholic fatty liver disease? BMJ 343, d3897 (2011).
  Article PubMed Google Scholar
• Sanyal, A. J. & American Gastroenterological Association. AGA technical review on nonalcoholic fatty liver disease. Gastroenterology 123, 1705–1725 (2002).
  Article PubMed Google Scholar
• Anstee, Q. M., Targher, G. & Day, C. P. Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis. Nat. Rev. Gastroenterol. Hepatol. 10, 330–344 (2013).
  Article CAS PubMed Google Scholar
• Ratziu, V., Bellentani, S., Cortez-Pinto, H., Day, C. & Marchesini, G. A position statement on NAFLD/NASH based on the EASL 2009 special conference. J. Hepatol. 53, 372–384 (2010).
  Article PubMed Google Scholar
• Das, K. et al. Nonobese population in a developing country has a high prevalence of nonalcoholic fatty liver and significant liver disease. Hepatology 51, 1593–1602 (2010).
  Article CAS PubMed Google Scholar
• Cobbold, J. F., Anstee, Q. M. & Taylor-Robinson, S. D. The importance of fatty liver disease in clinical practice. Proc. Nutr. Soc. 1–10 (2010).
• Musso, G., Gambino, R., Cassader, M. & Pagano, G. Meta-analysis: natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity. Ann. Med. 43, 617–649 (2011).
  Article PubMed Google Scholar
• Minervini, M. I. et al. Liver biopsy findings from healthy potential living liver donors: reasons for disqualification, silent diseases and correlation with liver injury tests. J. Hepatol. 50, 501–510 (2009).
  Article PubMed Google Scholar
• Nadalin, S. et al. Preoperative donor liver biopsy for adult living donor liver transplantation: risks and benefits. Liver Transpl. 11, 980–986 (2005).
  Article PubMed Google Scholar
• Tran, T. T. et al. Living donor liver transplantation: histological abnormalities found on liver biopsies of apparently healthy potential donors. J. Gastroenterol. Hepatol. 21, 381–383 (2006).
  Article PubMed Google Scholar
• Ryan, C. K., Johnson, L. A., Germin, B. I. & Marcos, A. One hundred consecutive hepatic biopsies in the workup of living donors for right lobe liver transplantation. Liver Transpl. 8, 1114–1122 (2002).
  Article PubMed Google Scholar
• Browning, J. D. et al. Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology 40, 1387–1395 (2004).
  Article PubMed Google Scholar
• Szczepaniak, L. S. et al. Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population. Am. J. Physiol. Endocrinol. Metab. 288, E462–E468 (2005).
  Article CAS PubMed Google Scholar
• Bellentani, S., Bedogni, G., Miglioli, L. & Tiribelli, C. The epidemiology of fatty liver. Eur. J. Gastroenterol. Hepatol. 16, 1087–1093 (2004).
  Article PubMed Google Scholar
• Argo, C. K. & Caldwell, S. H. Epidemiology and natural history of non-alcoholic steatohepatitis. Clin. Liver Dis. 13, 511–531 (2009).
  Article PubMed Google Scholar
• Targher, G. et al. Prevalence of nonalcoholic fatty liver disease and its association with cardiovascular disease among type 2 diabetic patients. Diabetes Care 30, 1212–1218 (2007).
  Article PubMed Google Scholar
• Jimba, S. et al. Prevalence of non-alcoholic fatty liver disease and its association with impaired glucose metabolism in Japanese adults. Diabet. Med. 22, 1141–1145 (2005).
  Article CAS PubMed Google Scholar
• Williams, C. D. et al. Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study. Gastroenterology 140, 124–131 (2011).
  Article PubMed Google Scholar
• Williamson, R. M. et al. Prevalence of and risk factors for hepatic steatosis and nonalcoholic fatty liver disease in people with type 2 diabetes: the Edinburgh Type 2 Diabetes Study. Diabetes Care 34, 1139–1144 (2011).
  Article PubMed PubMed Central Google Scholar
• Hirschhorn, J. N. & Gajdos, Z. K. Genome-wide association studies: results from the first few years and potential implications for clinical medicine. Annu. Rev. Med. 62, 11–24 (2011).
  Article CAS PubMed Google Scholar
• Altshuler, D., Daly, M. J. & Lander, E. S. Genetic mapping in human disease. Science 322, 881–888 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• International Human Genome Sequencing Consortium. Finishing the euchromatic sequence of the human genome. Nature 431, 931–945 (2004).
• Lander, E. S. et al. Initial sequencing and analysis of the human genome. Nature 409, 860–921 (2001).
  Article CAS PubMed Google Scholar
• Manolio, T. A., Brooks, L. D. & Collins, F. S. A HapMap harvest of insights into the genetics of common disease. J. Clin. Invest. 118, 1590–1605 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• International HapMap Consortium. The International HapMap Project. Nature 426, 789–796 (2003).
• International HapMap Consortium. A haplotype map of the human genome. Nature 437, 1299–1320 (2005).
• Frazer, K. A. et al. A second generation human haplotype map of over 3.1 million SNPs. Nature 449, 851–861 (2007).
  Article CAS PubMed Google Scholar
• Reich, D. E. & Lander, E. S. On the allelic spectrum of human disease. Trends Genet. 17, 502–510 (2001).
  Article CAS PubMed Google Scholar
• Wang, W. Y., Barratt, B. J., Clayton, D. G. & Todd, J. A. Genome-wide association studies: theoretical and practical concerns. Nat. Rev. Genet. 6, 109–118 (2005).
  Article CAS PubMed Google Scholar
• Pritchard, J. K. Are rare variants responsible for susceptibility to complex diseases? Am. J. Hum. Genet. 69, 124–137 (2001).
  Article CAS PubMed PubMed Central Google Scholar
• Hindorff, L. A. et al. Potential etiologic and functional implications of genome-wide association loci for human diseases and traits. Proc. Natl Acad. Sci. USA 106, 9362–9367 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Lohmueller, K. E., Pearce, C. L., Pike, M., Lander, E. S. & Hirschhorn, J. N. Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease. Nat. Genet. 33, 177–182 (2003).
  Article CAS PubMed Google Scholar
• Manolio, T. A. et al. Finding the missing heritability of complex diseases. Nature 461, 747–753 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Cardon, L. R. & Bell, J. I. Association study designs for complex diseases. Nat. Rev. Genet. 2, 91–99 (2001).
  Article CAS PubMed Google Scholar
• Hirschhorn, J. N. Genomewide association studies—illuminating biologic pathways. N. Engl. J. Med. 360, 1699–1701 (2009).
  Article CAS PubMed Google Scholar
• Hardy, J. & Singleton, A. Genomewide association studies and human disease. N. Engl. J. Med. 360, 1759–1768 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Hirschhorn, J. N. & Daly, M. J. Genome-wide association studies for common diseases and complex traits. Nat. Rev. Genet. 6, 95–108 (2005).
  Article CAS PubMed Google Scholar
• Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 447, 661–678 (2007).
• McCarthy, M. I. & Hirschhorn, J. N. Genome-wide association studies: past, present and future. Hum. Mol. Genet. 17, R100–R101 (2008).
  Article CAS PubMed Google Scholar
• Yuan, X. et al. Population-based genome-wide association studies reveal six loci influencing plasma levels of liver enzymes. Am. J. Hum. Genet. 83, 520–528 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Chambers, J. C. et al. Genome-wide association study identifies loci influencing concentrations of liver enzymes in plasma. Nat. Genet. 43, 1131–1138 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Daly, A. K. et al. HLA-B*5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin. Nat. Genet. 41, 816–819 (2009).
  Article CAS PubMed Google Scholar
• Buch, S. et al. A genome-wide association scan identifies the hepatic cholesterol transporter ABCG8 as a susceptibility factor for human gallstone disease. Nat. Genet. 39, 995–999 (2007).
  Article CAS PubMed Google Scholar
• Hirschfield, G. M. et al. Primary biliary cirrhosis associated with HLA, IL12A, and IL12RB2 variants. N. Engl. J. Med. 360, 2544–2555 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Liu, X. et al. Genome-wide meta-analyses identify three loci associated with primary biliary cirrhosis. Nat. Genet. 42, 658–660 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Mells, G. F. et al. Genome-wide association study identifies 12 new susceptibility loci for primary biliary cirrhosis. Nat. Genet. 43, 329–332 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Romeo, S. et al. Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease. Nat. Genet. 40, 1461–1465 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Chalasani, N. et al. Genome-wide association study identifies variants associated with histologic features of nonalcoholic fatty liver disease. Gastroenterology 139, 1567–1576 (2010).
  Article PubMed Google Scholar
• Speliotes, E. K. et al. Genome-wide association analysis identifies variants associated with nonalcoholic fatty liver disease that have distinct effects on metabolic traits. PLoS Genet. 7, e1001324 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Kamatani, Y. et al. A genome-wide association study identifies variants in the HLA-DP locus associated with chronic hepatitis B in Asians. Nat. Genet. 41, 591–595 (2009).
  Article CAS PubMed Google Scholar
• Ge, D. et al. Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance. Nature 461, 399–401 (2009).
  Article CAS PubMed Google Scholar
• Suppiah, V. et al. IL28B is associated with response to chronic hepatitis C interferon-α and ribavirin therapy. Nat. Genet. 41, 1100–1104 (2009).
  Article CAS PubMed Google Scholar
• Miele, L. et al. The Kruppel-like factor 6 genotype is associated with fibrosis in nonalcoholic fatty liver disease. Gastroenterology 135, 282–291 (2008).
  Article CAS PubMed Google Scholar
• Anstee, Q. M. et al. Genome-wide association analysis confirms importance of PNPLA3 and identifies novel variants associated with histologically progressive fibrosing steatohepatitis in NAFLD [abstract 146]. Hepatology 56 (Suppl. 1), 265A (2012).
  Google Scholar
• Kawaguchi, T. et al. Genetic polymorphisms of the human PNPLA3 gene are strongly associated with severity of non-alcoholic fatty liver disease in Japanese. PLoS ONE 7, e38322 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Feitosa, M. F. et al. The ERLIN1_–_CHUK_–_CWF19L1 gene cluster influences liver fat deposition and hepatic inflammation in the NHLBI Family Heart Study. Atherosclerosis 228, 175–180 (2013).
  Article CAS PubMed PubMed Central Google Scholar
• Victor, R. G. et al. The Dallas Heart Study: a population-based probability sample for the multidisciplinary study of ethnic differences in cardiovascular health. Am. J. Cardiol. 93, 1473–1480 (2004).
  Article PubMed Google Scholar
• Cobbold, J. F. et al. Phenotyping murine models of non-alcoholic fatty liver disease through metabolic profiling of intact liver tissue. Clin. Sci. (Lond.) 116, 403–413 (2009).
  Article CAS Google Scholar
• Siegelman, E. S. & Rosen, M. A. Imaging of hepatic steatosis. Semin. Liver Dis. 21, 71–80 (2001).
  Article CAS PubMed Google Scholar
• Romeo, S., Huang-Doran, I., Baroni, M. G. & Kotronen, A. Unravelling the pathogenesis of fatty liver disease: patatin-like phospholipase domain-containing 3 protein. Curr. Opin. Lipidol. 21, 247–252 (2010).
  Article CAS PubMed Google Scholar
• Gorden, A. et al. Genetic variation at NCAN locus is associated with inflammation and fibrosis in non-alcoholic fatty liver disease in morbid obesity. Hum. Hered. 75, 34–43 (2013).
  Article CAS PubMed Google Scholar
• Kathiresan, S. et al. Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans. Nat. Genet. 40, 189–197 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Teslovich, T. M. et al. Biological, clinical and population relevance of 95 loci for blood lipids. Nature 466, 707–713 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Kleiner, D. E. et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 41, 1313–1321 (2005).
  Article PubMed Google Scholar
• Ballestri, S., Day, C. P. & Daly, A. K. Polymorphism in the farnesyl diphosphate farnesyl transferase 1 gene and nonalcoholic fatty liver disease severity. Gastroenterology 140, 1694–1695 (2011).
  Article PubMed Google Scholar
• Kitamoto, T. et al. Genome-wide scan revealed that polymorphisms in the PNPLA3, SAMM50, and PARVB genes are associated with development and progression of nonalcoholic fatty liver disease in Japan. Hum. Genet. 132, 783–792 (2013).
  Article CAS PubMed Google Scholar
• Matteoni, C. A. et al. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology 116, 1413–1419 (1999).
  Article CAS PubMed Google Scholar
• Saadeh, S. et al. The utility of radiological imaging in nonalcoholic fatty liver disease. Gastroenterology 123, 745–750 (2002).
  Article PubMed Google Scholar
• Schwenzer, N. F. et al. Non-invasive assessment and quantification of liver steatosis by ultrasound, computed tomography and magnetic resonance. J. Hepatol. 51, 433–445 (2009).
  Article PubMed Google Scholar
• Dasarathy, S. et al. Validity of real time ultrasound in the diagnosis of hepatic steatosis: a prospective study. J. Hepatol. 51, 1061–1067 (2009).
  Article PubMed PubMed Central Google Scholar
• Mofrad, P. et al. Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT values. Hepatology 37, 1286–1292 (2003).
  Article PubMed Google Scholar
• Vernon, G., Baranova, A. & Younossi, Z. M. Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults. Aliment. Pharmacol. Ther. 34, 274–285 (2011).
  Article CAS PubMed Google Scholar
• Armstrong, M. J. et al. Presence and severity of non-alcoholic fatty liver disease in a large prospective primary care cohort. J. Hepatol. 56, 234–240 (2012).
  Article PubMed Google Scholar
• Aulchenko, Y. S. et al. Loci influencing lipid levels and coronary heart disease risk in 16 European population cohorts. Nat. Genet. 41, 47–55 (2009).
  Article CAS PubMed Google Scholar
• Willer, C. J. et al. Newly identified loci that influence lipid concentrations and risk of coronary artery disease. Nat. Genet. 40, 161–169 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Valenti, L. et al. Homozygosity for the patatin-like phospholipase-3/adiponutrin I148M polymorphism influences liver fibrosis in patients with nonalcoholic fatty liver disease. Hepatology 51, 1209–1217 (2010).
  Article CAS PubMed Google Scholar
• Kotronen, A. et al. A common variant in PNPLA3, which encodes adiponutrin, is associated with liver fat content in humans. Diabetologia 52, 1056–1060 (2009).
  Article CAS PubMed Google Scholar
• Sookoian, S. et al. A nonsynonymous gene variant in the adiponutrin gene is associated with nonalcoholic fatty liver disease severity. J. Lipid Res. 50, 2111–2116 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Kantartzis, K. et al. Dissociation between fatty liver and insulin resistance in humans carrying a variant of the patatin-like phospholipase 3 gene. Diabetes 58, 2616–2623 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Rotman, Y., Koh, C., Zmuda, J. M., Kleiner, D. E. & Liang, T. J. The association of genetic variability in patatin-like phospholipase domain-containing protein 3 (PNPLA3) with histological severity of nonalcoholic fatty liver disease. Hepatology 52, 894–903 (2010).
  Article CAS PubMed Google Scholar
• Romeo, S. et al. The 148M allele of the PNPLA3 gene is associated with indices of liver damage early in life. J. Hepatol. 53, 335–338 (2010).
  Article CAS PubMed Google Scholar
• Valenti, L. et al. I148M patatin-like phospholipase domain-containing 3 gene variant and severity of pediatric nonalcoholic fatty liver disease. Hepatology 52, 1274–1280 (2010).
  Article CAS PubMed Google Scholar
• Santoro, N. et al. A common variant in the patatin-like phospholipase 3 gene (PNPLA3) is associated with fatty liver disease in obese children and adolescents. Hepatology 52, 1281–1290 (2010).
  Article CAS PubMed Google Scholar
• Kollerits, B. et al. A common variant in the adiponutrin gene influences liver enzyme values. J. Med. Genet. 47, 116–119 (2010).
  Article CAS PubMed Google Scholar
• Liu, Y.-L. et al. Carriage of PNPLA3 I148M is associated with an increased risk of non-alcoholic fatty liver diesease associated hepatocellular carcinoma [abstract 1275]. J. Hepatol. 58, S516 (2013).
  Article Google Scholar
• Hassan, M. M. et al. Genetic variation in the PNPLA3 gene and hepatocellular carcinoma in USA: risk and prognosis prediction. Mol. Carcinog. http://dx.doi.org/10.1002/mc.22057.
• Zimmermann, R. et al. Fat mobilization in adipose tissue is promoted by adipose triglyceride lipase. Science 306, 1383–1386 (2004).
  Article CAS PubMed Google Scholar
• Rydel, T. J. et al. The crystal structure, mutagenesis, and activity studies reveal that patatin is a lipid acyl hydrolase with a Ser-Asp catalytic dyad. Biochemistry 42, 6696–6708 (2003).
  Article CAS PubMed Google Scholar
• He, S. et al. A sequence variation (I148M) in PNPLA3 associated with nonalcoholic fatty liver disease disrupts triglyceride hydrolysis. J. Biol. Chem. 285, 6706–6715 (2010).
  Article CAS PubMed Google Scholar
• Romeo, S. et al. Morbid obesity exposes the association between PNPLA3 I148M (rs738409) and indices of hepatic injury in individuals of European descent. Int. J. Obes. (Lond.) 34, 190–194 (2010).
  Article CAS Google Scholar
• Speliotes, E. K., Butler, J. L., Palmer, C. D., Voight, B. F. & Hirschhorn, J. N. PNPLA3 variants specifically confer increased risk for histologic nonalcoholic fatty liver disease but not metabolic disease. Hepatology 52, 904–912 (2010).
  Article CAS PubMed Google Scholar
• Huang, Y., Cohen, J. C. & Hobbs, H. H. Expression and characterization of a PNPLA3 protein isoform (I148M) associated with nonalcoholic fatty liver disease. J. Biol. Chem. 286, 37085–37093 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Pirazzi, C. et al. Patatin-like phospholipase domain-containing 3 (PNPLA3) I148M (rs738409) affects hepatic VLDL secretion in humans and in vitro. J. Hepatol. 57, 1276–1282 (2012).
  Article CAS PubMed Google Scholar
• Jenkins, C. M. et al. Identification, cloning, expression, and purification of three novel human calcium-independent phospholipase A2 family members possessing triacylglycerol lipase and acylglycerol transacylase activities. J. Biol. Chem. 279, 48968–48975 (2004).
  Article CAS PubMed Google Scholar
• Kumari, M. et al. Adiponutrin functions as a nutritionally regulated lysophosphatidic acid acyltransferase. Cell Metab. 15, 691–702 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Huang, Y. et al. A feed-forward loop amplifies nutritional regulation of PNPLA3. Proc. Natl Acad. Sci. USA 107, 7892–7897 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Wilson, P. A., Gardner, S. D., Lambie, N. M., Commans, S. A. & Crowther, D. J. Characterization of the human patatin-like phospholipase family. J. Lipid Res. 47, 1940–1949 (2006).
  Article CAS PubMed Google Scholar
• Hoekstra, M. et al. The expression level of non-alcoholic fatty liver disease-related gene PNPLA3 in hepatocytes is highly influenced by hepatic lipid status. J. Hepatol. 52, 244–251 (2010).
  Article CAS PubMed Google Scholar
• Lake, A. C. et al. Expression, regulation, and triglyceride hydrolase activity of adiponutrin family members. J. Lipid Res. 46, 2477–2487 (2005).
  Article CAS PubMed Google Scholar
• Chen, W., Chang, B., Li, L. & Chan, L. Patatin-like phospholipase domain-containing 3/adiponutrin deficiency in mice is not associated with fatty liver disease. Hepatology 52, 1134–1142 (2010).
  Article CAS PubMed Google Scholar
• Basantani, M. K. et al. Pnpla3/Adiponutrin deficiency in mice does not contribute to fatty liver disease or metabolic syndrome. J. Lipid Res. 52, 318–329 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Li, J. Z. et al. Chronic overexpression of PNPLA3 I148M in mouse liver causes hepatic steatosis. J. Clin. Invest. 122, 4130–4144 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Wree, A. et al. From NAFLD to NASH to cirrhosis—new insights into disease mechanisms. Nat. Rev. Gastroenterol. Hepatol. http://dx.doi.org/10.1038/nrgastro.2013.149.
• Anstee, Q. M. & Goldin, R. D. Mouse models in non-alcoholic fatty liver disease and steatohepatitis research. Int. J. Exp. Pathol. 87, 1–16 (2006).
  Article CAS PubMed PubMed Central Google Scholar
• Yamaguchi, K. et al. Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis. Hepatology 45, 1366–1374 (2007).
  Article CAS PubMed Google Scholar
• Malhi, H., Gores, G. J. & Lemasters, J. J. Apoptosis and necrosis in the liver: a tale of two deaths? Hepatology 43, S31–S44 (2006).
  Article CAS PubMed Google Scholar
• Anstee, Q. M. et al. Impact of pan-caspase inhibition in animal models of established steatosis and non-alcoholic steatohepatitis. J. Hepatol. 53, 542–550 (2010).
  Article CAS PubMed Google Scholar
• Farrell, G. C. et al. Apoptosis in experimental NASH is associated with p53 activation and TRAIL receptor expression. J. Gastroenterol. Hepatol. 24, 443–452 (2009).
  Article CAS PubMed Google Scholar
• Iredale, J. P. Models of liver fibrosis: exploring the dynamic nature of inflammation and repair in a solid organ. J. Clin. Invest. 117, 539–548 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Spielman, R. S. & Ewens, W. J. The TDT and other family-based tests for linkage disequilibrium and association. Am. J. Hum. Genet. 59, 983–989 (1996).
  CAS PubMed PubMed Central Google Scholar
• Tan, H. L. et al. Association of glucokinase regulatory gene polymorphisms with risk and severity of non-alcoholic fatty liver disease: an interaction study with adiponutrin gene. J. Gastroenterol. http://dx.doi.org/10.1007/s00535-013-0850-x.
• Palmer, N. D. et al. Characterization of european ancestry nonalcoholic fatty liver disease-associated variants in individuals of african and hispanic descent. Hepatology 58, 966–975 (2013).
  Article CAS PubMed Google Scholar
• Namikawa, C. et al. Polymorphisms of microsomal triglyceride transfer protein gene and manganese superoxide dismutase gene in non-alcoholic steatohepatitis. J. Hepatol. 40, 781–786 (2004).
  Article CAS PubMed Google Scholar
• Al-Serri, A. et al. The SOD2 C47T polymorphism influences NAFLD fibrosis severity: evidence from case-control and intra-familial allele association studies. J. Hepatol. 56, 448–454 (2012).
  Article CAS PubMed Google Scholar
• Dong, H. et al. The phosphatidylethanolamine _N_-methyltransferase gene V175M single nucleotide polymorphism confers the susceptibility to NASH in Japanese population. J. Hepatol. 46, 915–920 (2007).
  Article CAS PubMed Google Scholar
• Song, J. et al. Polymorphism of the PEMT gene and susceptibility to nonalcoholic fatty liver disease (NAFLD). FASEB J. 19, 1266–1271 (2005).
  Article CAS PubMed Google Scholar
• Yoneda, M. et al. Association between angiotensin II type 1 receptor polymorphisms and the occurrence of nonalcoholic fatty liver disease. Liver Int. 29, 1078–1085 (2009).
  Article CAS PubMed Google Scholar
• Zain, S. M. et al. Susceptibility and gene interaction study of the angiotensin II type 1 receptor (AGTR1) gene polymorphisms with non-alcoholic fatty liver disease in a multi-ethnic population. PLoS ONE 8, e58538 (2013).
  Article CAS PubMed PubMed Central Google Scholar
• Narla, G. et al. A germline DNA polymorphism enhances alternative splicing of the KLF6 tumor suppressor gene and is associated with increased prostate cancer risk. Cancer Res. 65, 1213–1222 (2005).
  Article CAS PubMed Google Scholar
• Beer, N. L. et al. The P446L variant in GCKR associated with fasting plasma glucose and triglyceride levels exerts its effect through increased glucokinase activity in liver. Hum. Mol. Genet. 18, 4081–4088 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Santoro, N. et al. Variant in the glucokinase regulatory protein (GCKR) gene is associated with fatty liver in obese children and adolescents. Hepatology 55, 781–789 (2011).
  Article CAS PubMed Google Scholar
• Valenti, L., Alisi, A. & Nobili, V. Unraveling the genetics of fatty liver in obese children: Additive effect of P446L GCKR and I148M PNPLA3 polymorphisms. Hepatology 55, 661–663 (2012).
  Article PubMed Google Scholar
• Ratziu, V. et al. Zf9, a Kruppel-like transcription factor up-regulated in vivo during early hepatic fibrosis. Proc. Natl Acad. Sci. USA 95, 9500–9505 (1998).
  Article CAS PubMed PubMed Central Google Scholar
• Starkel, P. et al. Oxidative stress, KLF6 and transforming growth factor-beta up-regulation differentiate non-alcoholic steatohepatitis progressing to fibrosis from uncomplicated steatosis in rats. J. Hepatol. 39, 538–546 (2003).
  Article CAS PubMed Google Scholar
• Bechmann, L. P. et al. Glucokinase links Kruppel-like factor 6 to the regulation of hepatic insulin sensitivity in nonalcoholic fatty liver disease. Hepatology 55, 1083–1093 (2012).
  Article CAS PubMed Google Scholar
• Oakley, F. et al. Angiotensin II activates IκB kinase phosphorylation of RelA at Ser536 to promote myofibroblast survival and liver fibrosis. Gastroenterology 136, 2334–2344 (2009).
  Article CAS PubMed Google Scholar
• Dixon, J. B. et al. Pro-fibrotic polymorphisms predictive of advanced liver fibrosis in the severely obese. J. Hepatol. 39, 967–971 (2003).
  Article CAS PubMed Google Scholar
• Yokohama, S. et al. Therapeutic efficacy of an angiotensin II receptor antagonist in patients with nonalcoholic steatohepatitis. Hepatology 40, 1222–1225 (2004).
  Article CAS PubMed Google Scholar
• Ginsberg, H. N. et al. Apolipoprotein B metabolism in subjects with deficiency of apolipoproteins CIII and AI. Evidence that apolipoprotein CIII inhibits catabolism of triglyceride-rich lipoproteins by lipoprotein lipase in vivo. J. Clin. Invest. 78, 1287–1295 (1986).
  Article CAS PubMed PubMed Central Google Scholar
• Petersen, K. F. et al. Apolipoprotein C3 gene variants in nonalcoholic fatty liver disease. N. Engl. J. Med. 362, 1082–1089 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Kozlitina, J., Boerwinkle, E., Cohen, J. C. & Hobbs, H. H. Dissociation between APOC3 variants, hepatic triglyceride content and insulin resistance. Hepatology 53, 467–474 (2011).
  Article CAS PubMed Google Scholar
• Valenti, L. et al. The APOC3 T–455C and C–482T promoter region polymorphisms are not associated with the severity of liver damage in patients with nonalcoholic fatty liver. J. Hepatol. 55, 1409–1414 (2012).
  Article CAS Google Scholar
• Verrijken, A. et al. A gene variant of PNPLA3, but not of APOC3, is associated with histological parameters of NAFLD in an obese population. Obesity (Silver Spring) http://dx.doi.org/10.1002/oby.20366.
• Sentinelli, F. et al. Lack of effect of apolipoprotein C3 polymorphisms on indices of liver steatosis, lipid profile and insulin resistance in obese Southern Europeans. Lipids Health Dis. 10, 93 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Zeybel, M. et al. Multigenerational epigenetic adaptation of the hepatic wound-healing response. Nat. Med. 18, 1369–1377 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Willner, I. R. et al. Ninety patients with nonalcoholic steatohepatitis: insulin resistance, familial tendency, and severity of disease. Am. J. Gastroenterol. 96, 2957–2961 (2001).
  Article CAS PubMed Google Scholar
• Struben, V. M., Hespenheide, E. E. & Caldwell, S. H. Nonalcoholic steatohepatitis and cryptogenic cirrhosis within kindreds. Am. J. Med. 108, 9–13 (2000).
  Article CAS PubMed Google Scholar
• Schwimmer, J. B. et al. Heritability of nonalcoholic fatty liver disease. Gastroenterology 136, 1585–1592 (2009).
  Article PubMed Google Scholar
• Makkonen, J., Pietilainen, K. H., Rissanen, A., Kaprio, J. & Yki-Jarvinen, H. Genetic factors contribute to variation in serum alanine aminotransferase activity independent of obesity and alcohol: a study in monozygotic and dizygotic twins. J. Hepatol. 50, 1035–1042 (2009).
  Article CAS PubMed Google Scholar
• Browning, J. D., Kumar, K. S., Saboorian, M. H. & Thiele, D. L. Ethnic differences in the prevalence of cryptogenic cirrhosis. Am. J. Gastroenterol. 99, 292–298 (2004).
  Article PubMed Google Scholar
• Guerrero, R., Vega, G. L., Grundy, S. M. & Browning, J. D. Ethnic differences in hepatic steatosis: an insulin resistance paradox? Hepatology 49, 791–801 (2009).
  Article PubMed Google Scholar
• Bambha, K. et al. Ethnicity and nonalcoholic fatty liver disease. Hepatology 55, 769–780 (2012).
  Article CAS PubMed Google Scholar
• Perttila, J. et al. PNPLA3 is regulated by glucose in human hepatocytes, and its I148M mutant slows down triglyceride hydrolysis. Am. J. Phys. Endo. Met. 302, E1063–E1069 (2012).
  CAS Google Scholar